Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Predictive tests for EGFR inhibitors.

Clinical advances in hematology & oncology : H&O - 1 Sept 2005

Lynch Thomas J

Abstract excerpt

No abstract is available from the source.

Topics

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biological Assay
Breast Neoplasms
Drug Design
ErbB Receptors
Female
Gene Dosage
Humans
Lung Neoplasms
Male
Mutation
Predictive Value of Tests
Protein Kinase Inhibitors
Signal Transduction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Trastuzumab

Source

Identifiers

PMID: 16224439

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive tests for EGFR inhibitors.PMID 16224439Read ↗

EGFR testing in lung cancer is ready for prime time.Semantic proximity Read ↗

Rapid screening for EGFR mutations: pros and cons.Semantic proximity Read ↗

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS.Semantic proximity Read ↗

EGFR mutations and EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

EGFR pharmacogenomics: the story continues to mutate and evolve.Semantic proximity Read ↗

Use of molecular markers for predicting therapy response in cancer patients.Semantic proximity Read ↗

Usefulness of predictive tests for cancer treatment.Semantic proximity Read ↗

EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation.Semantic proximity Read ↗

[Current update and testing procedures for genetic diagnosis in malignant neoplasm: additional information on pathological tests].Semantic proximity Read ↗

Biomarker testing in non-small cell lung cancer: a clinician's perspective.Semantic proximity Read ↗

Market watch: emerging companion diagnostics for cancer drugs.Semantic proximity Read ↗

EGFR antagonists in cancer treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.